Decreased red blood cell aggregation subsequent to improved glycaemic control in type 2 diabetes mellitus

Diabetic Medicine

Volumn 20, Issue 4, 2003, Pages 301-306

  Chong Martinez, B ^a,b   Buchanan, T A ^b   Wenby, R B ^b   Meiselman, Herbert J ^b  

^a Internal Medicine Department   (Mexico)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Aggregation; Diabetes mellitus; Red blood cell; Rheology; Therapy

Indexed keywords

CHOLESTEROL; DEXTRAN; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD VISCOSITY; CHOLESTEROL BLOOD LEVEL; DIET; DIET RESTRICTION; ERYTHROCYTE AGGREGATION; EXERCISE; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA VISCOSITY; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

ADULT; AGED; BLOOD GLUCOSE; BLOOD VISCOSITY; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED;

EID: 0038813677     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00926.x     Document Type: Article

References (48)

1. Stuart J, Juhan-Vague I. Erythrocyte rheology in diabetes mellitus. Clin Hemorheol 1987; 7: 239-245.
2. Barnes AJ. Rheology of diabetes mellitus. In Lowe GDO ed. Clinical Blood Rheology. Boca Raton: CRC Press, 1988: 163-187.
3. MacRury SM, Lowe GDO. Blood rheology in diabetes mellitus. Diabet Med 1980; 7: 285-291.
4. LeDevehat C, Khodabandelou T, Vimeux M, Aouane F. Diabetes mellitus - its effects in blood rheological properties and microcirculatory consequences. Clin Hemorheol 1996; 16: 677-683.
5. Rampling MW. Haemorheological disturbances in hypertension: the influence of diabetes and smoking. Clin Hemorheol Microcirc 1999; 21: 183-187.
6. Ziegler O, Guerci B, Muller S, Candiloros H, Mejean I, Donner M et al. Increased erythrocyte aggregation in insulin-dependent diabetes mellitus and its relationship to plasma factors: a multivariate analysis. Metabolism 1994; 43: 1182-1186.
7. Bauersachs RM, Shaw SJ, Zeidler A, Meiselman HJ. Red blood cell aggregation and blood viscoelasticity in poorly controlled type 2 diabetes mellitus. Clin Hemorheol 1989; 9: 935-952.
8. Le Devehat C, Khodabandehlou T, Vimeux M. Impaired hemorheological properties in diabetic patients with lower limb ischemia. Clin Hemorheol Microcirc 2001; 25: 43-48.
9. Petit KI, Hunt WB, George SJ, Barnes AJ. Is impaired red cell filtration in diabetics due to a small abnormal sub-population of cells? Clin Hemorheol 1996; 16: 479-485.
10. Ernst E, Matrai A. Altered red and white blood cell rheology in type II diabetes. Diabetes 1986; 35: 1412-1415.
11. Williamson JR, Gardner RA, Boylan CW, Carroll GL, Chang K, Marvel JS et al. Microrheologic investigation of erythrocyte deformability in diabetes mellitus. Blood 1985; 65: 283-288.
12. Bareford D, Jennings PE, Stone PC, Baar S, Barnett AH, Stuart J. Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus. J Clin Pathol 1986; 39: 722-727.
13. Sewchand LS, Hampel WL, Diddie KR, Meiselman HJ. Membrane mechanical properties of erythrocytes from patients with diabetic retinopathy. Microcirculation 1982; 1: 361-380.
14. Pecsvarady Z, Fisher TC, Darwin CH, Fabok A, Maqueda TS, Saad MF et al. Decreased polymorphonuclear leukocyte deformability in NIDDM. Diabetes Care 1994; 17: 57-63.
15. Missirlis Y, Kaleridis V. Polymorphonuclear leukocyte deformability in type II diabetes mellitus in ageing. Clin Hemorheol 1994; 14: 489-495.
16. Linderkamp O, Ruef P, Zilow EP, Hoffmann GF. Impaired deformability of erythrocytes and neutrophils in children with newly diagnosed insulin-dependent diabetes mellitus. Diabetologia 1999; 42: 865-869.
17. Braun RD, Fisher TC, Meiselman HJ, Hatchell DL. Decreased deformability of polymorphonuclear leukocytes in diabetic cats. Microcirculation 1996; 3: 271-278.
18. Juhan I, Vague PH, Buonocore M, Moulin JP, Calas MF, Vialettes B et al. Effects of insulin on erythrocyte deformability in diabetics -relationship between erythrocyte deformability and platelet aggregation. Scand J Clin Lab Invest 1981; 41: 159-164.
19. Coppola L, Verrazzo G, LaMarca C, Ziccardi P, Tirelli A, Giugliano D. Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus. Diabet Med 1997; 14: 959-963.
20. Le Devehat C, Khodabandehlou T, Zhao H, Vimeux M. Role and limits of glycemic regulation in the pathogenesis of diabetic microangiopathy. Clin Hemorheol Microcirc 1997; 17: 363-370.
21. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25: S50-S60.
22. Dujovne CA, Harris WS, Altman R, Overhiser RW, Black DM. Effect of Atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am J Cardiol 2000; 85: 350-353.
23. Meiselman HJ. Red blood cell role in RBC aggregation: 1963-1993 and beyond. Clin Hemorheol 1993; 13: 575-592.
24. Toth K, Wenby RB, Meiselman HJ. Inhibition of polymer-induced red blood cell aggregation by poloxamer 188. Biorheology 2000; 37: 301-312.
25. Meiselman HJ, Castellini MA, Elsner R. Hemorheological behavior of seal blood. Clin Hemorheol 1992; 12: 657-675.
26. Bauersachs RM, Wenby RB, Meiselman HJ. Determination of specific red blood cell aggregation indices via an automated system. Clin Hemorheol 1989; 9: 1-25.
27. Cooke BM, Stuart J. Automated measurement of plasma viscosity by capillary viscometer. J Clin Pathol 1988; 41: 1213-1216.
28. Rumley A, Woodward M, Hoffmeister A, Koenig W, Lowe GDO. Comparison of three plasma fibrinogen assays in a random population. Br J Haematol 1999; 105 (1S) (Suppl. 40).
29. Chien S. Biophysical behavior of red cells in suspensions. In Surgenor DM ed. The Red Blood Cell. New York: Academic Press, 1975: 1031-1133.
30. Cokelet GR. Rheology and hemodynamics. Ann Rev Physiol 1980; 42: 311-324.
31. Lowe GDO. Clinical Blood Rheology. Boca Raton: CRC Press, 1988.
32. Rosenson RS, Shott S, Tangney CC. Hypertriglyceridemia is associated with an elevated blood viscosity. Atherosclerosis 2002; 161: 433-439.
33. Kameneva MV, Watach MJ, Borovetz HS. Gender difference in rheologic properties of blood and risk of cardiovascular disease. Clin Hemorheol Microcirc 1999; 21: 357-363.
34. Rapaport SI. Introduction to Hematology. New York: J B Lippincott Co., 1987.
35. Miller JA, Gravallese E, Bunn HF. Non-enzymatic glycosylation of erythrocyte membrane protein, relevance to diabetes. J Clin Invest 1980; 65: 896-901.
36. McMillan DE, Brooks SM. Erythrocyte spectrin glycosylation in diabetes. Diabetes 1982; 31: 64-69.
37. Juhan-Vague I, Rahmani-Jourdheuil D, Mishal Z, Roul C, Mourayre Y, Aillaud MF et al. Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from Type 1 diabetic patients. Diabetologia 1986; 29: 417-420.
38. Martinez M, Vaya A, Server R, Gilsanz A, Aznar J. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane. Clin Hemorheol Microcirc 1998; 18: 253-258.
39. Shurtz-Swirski R, Sela S, Herskovits AT, Shasha SM, Shapiro G, Nasser L et al. Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in Type 2 diabetic patients. Diabetes Care 2001; 24: 104-110.
40. Baskurt OK, Meiselman HJ. Activated polymorphonuclear leukocytes affect red blood cell aggregability. J Leuk Biol 1998; 63: 89-93.
41. Baskurt OK, Temiz A, Meiselman HJ. Effect of superoxide anions on red blood cell rheologic properties. Free Rad Biol Med 1998; 24: 102-110.
42. Sowemimo-Coker SO, Whittingstall P, Pietsch L, Bauersachs RM, Wenby RB, Meiselman HJ. Effects of cellular factors on the aggregation behavior of human, rat and bovine erythrocytes. Clin Hemorheol 1989; 9: 723-737.
43. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
44. Soutani M, Suzuki Y, Tateishi N, Maeda N. Quantitative evaluation of flow dynamics of erythrocytes in microvessels: influence of erythrocyte aggregation. Am J Physiol 1995; 268: H1959-1965.
45. Vicaut E, Hoo X, Decuypere L, Taccoen A, Duvelleroy M. Red blood cell aggregation and microcirculation in rat cremaster muscle. Int J Microcirc 1994; 14: 14-21.
46. Baskurt O, Edremitlioglu M. Myocardial hematocrit: existence of a transmural gradient and alterations after fibrinogen infusions. Clin Hemorheol 1995; 15: 97-105.
47. Durussel JJ, Berthault MF, Guiffant G, Dufaux G. Effects of red blood cell aggregation on the rat microcirculation blood flow. Acta Physiol Scand 1998; 163: 25-32.
48. Cabel M, Meiselman HJ, Popel AS, Johnson PC. Contribution of red cell aggregation to venous vascular resistance in skeletal muscle. Am J Physiol 1997; 272: H1020-1032.